We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > OB-002

News List

Orion Biotechnology Receives Funding to Test OB-002 for COVID-19 americanpharmaceuticalreview
August 11, 2020
Orion Biotechnology Canada announced it is receiving advisory services and conditional funding from the National Research Council Industrial Research Assistance Program (NRC IRAP), to support the development of Orion’s lead compound, OB-002 ...
Orion Biotechnology Receives Funding to Develop OB-002 contractpharma
July 31, 2020
Orion Biotechnology Canada Ltd., a clinical stage pharmaceutical company, is receiving advisory services and conditional funding from the National Research Council Industrial Research Assistance Program (NRC IRAP) to support the development of Orion’s ...